Key points Cardiovascular outcome trials in individuals with type 2 diabetes mellitus demonstrate that glucagon-like peptide 1 (GLP1) receptor (GLP1R) agonists reduce the rates of non-fatal myocardial infarction, non-fatal stroke and cardiovascular death
The unique advantage of retatrutide, its ability to increase energy expenditure and fat oxidation beyond what GLP-1/GIP alone achieve, may depend on reaching peak concentrations that only weekly dosing reliably provides
Sodium, potassium, and magnesium are the big three to watch
Do not use mouth-drying agents like alcohol-based mouthwash
At NuLife Health & Wellness, we believe that weight loss is a gradual process requiring commitment and consistency
Stopping Wegovy may cause weight regain, so ongoing healthy habits and medical supervision are essential for sustaining weight loss and overall health